Alain Ravaud
University Hospital, Bordeaux · Hopital Saint Andre · University Hospital, Bordeaux, France
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alain Ravaud as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:13 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04070950 · Sexuality of Women With Pelvic CancerUniversity Hospital, Bordeaux · completed · Sexual Behavior, Pelvic Cancer · principal investigator
- Ph2NCT03324282 · First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder CarcinomaUniversity Hospital, Bordeaux · terminated · Bladder Carcinoma · principal investigator
- Ph1NCT01334073 · Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid TumorsUniversity Hospital, Bordeaux · completed · Malignant Advanced Solid Tumors, Carcinoma, Renal Cell · principal investigator
- Ph2NCT00541008 · Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell CancerUNICANCER · completed · Kidney Cancer · unknown
- Ph2NCT00510640 · Thyroid Cancer and SunitinibUniversity Hospital, Bordeaux · completed · Cancer, Thyroid Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:13 UTC. The ranking covers the 200 most relevant of 101 PubMed records, and a shared surname and initials can bring in a namesake. All 101 on PubMed
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.N Engl J Med · 20154,774 citationsRCR 147.0
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.N Engl J Med · 20183,807 citationsRCR 135.1
- 2,485 citationsRCR 54.0
- 1,791 citationsRCR 39.3
- 1,141 citationsRCR 38.0
- 1,038 citationsRCR 31.3
- Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors.Cancer · 2010973 citationsRCR 22.8
- 826 citationsRCR 28.5
- Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.N Engl J Med · 1998799 citationsRCR 16.7
- Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.N Engl J Med · 2018746 citationsRCR 28.0